Literature DB >> 25996252

Should be there specific guidelines to improve reporting of clinical pharmacology trials?

Yoon K Loke1.   

Abstract

Mesh：

Year:  2015        PMID： 25996252      PMCID： PMC4541963          DOI： 10.1111/bcp.12683

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

Review 1.  Describing reporting guidelines for health research: a systematic review.

Authors:  David Moher; Laura Weeks; Mary Ocampo; Dugald Seely; Margaret Sampson; Douglas G Altman; Kenneth F Schulz; Donald Miller; Iveta Simera; Jeremy Grimshaw; John Hoey
Journal:  J Clin Epidemiol       Date:  2011-01-08       Impact factor: 6.437

2.  CONSORT for reporting randomised trials in journal and conference abstracts.

Authors:  Sally Hopewell; Mike Clarke; David Moher; Elizabeth Wager; Philippa Middleton; Douglas G Altman; Kenneth F Schulz
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

3.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

4.  Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.

Authors:  Lesley A Stewart; Mike Clarke; Maroeska Rovers; Richard D Riley; Mark Simmonds; Gavin Stewart; Jayne F Tierney
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

5.  Researchers, readers, and reporting guidelines: writing between the lines.

Authors:  Robert M Golub; Phil B Fontanarosa
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

6.  Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement.

Authors:  Salmaan Kanji; Meghan Hayes; Adam Ling; Larissa Shamseer; Clarence Chant; David J Edwards; Scott Edwards; Mary H H Ensom; David R Foster; Brian Hardy; Tyree H Kiser; Charles la Porte; Jason A Roberts; Rob Shulman; Scott Walker; Sheryl Zelenitsky; David Moher
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

7.  Determining the reporting quality of RCTs in clinical pharmacology.

Authors:  Edward Mills; Yoon K Loke; Ping Wu; Victor M Montori; Daniel Perri; David Moher; Gordon Guyatt
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

8.  Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals.

Authors:  Allison Hirst; Douglas G Altman
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Guidance for developers of health research reporting guidelines.

Authors:  David Moher; Kenneth F Schulz; Iveta Simera; Douglas G Altman
Journal:  PLoS Med       Date:  2010-02-16       Impact factor: 11.069
  9 in total
  1 in total

1.  How publication guidelines for clinical pharmacology trials may help to accelerate knowledge transfer.

Authors:  Arne Ring; Kerstin Breithaupt-Grögler
Journal:  Br J Clin Pharmacol       Date:  2018-02-09       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.